The presented studies suggest that adenosinergic activation of A1 receptor regulating inflammatory cytokine TNF-α and IL-6 production is altered in MS, probably due to alterations at transcriptional levels of A1 receptor and/or to adenosine availability (Mayne et al., 1999; Johnston et al., 2001). The gene discussed is IL6; the disease is myeloid sarcoma.